S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2

被引:78
作者
Shaw, SS
Schmidt, AM
Banes, AK
Wang, XD
Stern, DM
Marrero, MB [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
[2] Columbia Univ, Dept Surg, New York, NY USA
[3] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA
关键词
D O I
10.2337/diabetes.52.9.2381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin II (Ang II), a vasoactive peptide that is also considered a growth factor, has been implicated in both normal and diabetic cellular proliferation. We recently found that activation of janus kinase 2 (JAK2) is essential for the Ang II-induced proliferation of vascular smooth muscle cells (VSMCs) and that high glucose augments Ang II-induced proliferation of VSMCs by increasing signal transduction through activation of JAK2. Here, we demonstrate that S100B, a ligand for the receptor of advanced glycation end products (RAGEs), augmented both Ang II-induced tyrosine phosphorylation of JAK2 and cell proliferation in VSMCs in a receptor-dependent manner. We also found that S100B-RAGE interaction triggered intracellular generation of reactive oxygen species (ROS), VSMC proliferation, and JAK2 tyrosine phosphorylation via activation of phospholipase D (PLD)2. These results provide direct evidence for linkages between PLD2, ROS production, and S100B-RAGE-induced enhancement of Ang II-induced cell proliferation and activation of JAK2 in VSMCs.
引用
收藏
页码:2381 / 2388
页数:8
相关论文
共 34 条
[1]   Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells [J].
Amiri, F ;
Venema, VJ ;
Wang, XD ;
Ju, H ;
Venema, RC ;
Marrero, MB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32382-32386
[2]   Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose [J].
Amiri, F ;
Shaw, S ;
Wang, XD ;
Tang, J ;
Waller, JL ;
Eaton, DC ;
Marrero, MB .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1605-1616
[3]   Angiotensin II signal transduction in vascular smooth muscle - Role of tyrosine kinases [J].
Berk, BC ;
Corson, MA .
CIRCULATION RESEARCH, 1997, 80 (05) :607-616
[4]  
Berk Bradford C., 1996, P187
[5]  
Bierhaus A, 1997, CIRCULATION, V96, P2262
[6]   AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept [J].
Bierhaus, A ;
Hofmann, MA ;
Ziegler, R ;
Nawroth, PP .
CARDIOVASCULAR RESEARCH, 1998, 37 (03) :586-600
[7]   USE OF AN AQUEOUS SOLUBLE TETRAZOLIUM FORMAZAN ASSAY TO MEASURE VIABILITY AND PROLIFERATION OF LYMPHOKINE-DEPENDENT CELL-LINES [J].
BUTTKE, TM ;
MCCUBREY, JA ;
OWEN, TC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 157 (1-2) :233-240
[8]   Advanced glycation end products, oxidant stress and vascular lesions [J].
Chappey, O ;
Dosquet, C ;
Wautier, MP ;
Wautier, JL .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (02) :97-108
[9]   Drug therapy - Angiotensin receptors and their antagonists [J].
Goodfriend, TL ;
Elliott, ME ;
Catt, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (25) :1649-1654
[10]   Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro [J].
Grandis, JR ;
Drenning, SD ;
Chakraborty, A ;
Zhou, MY ;
Zeng, Q ;
Tweardy, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1385-1392